Literature DB >> 1534082

Loss of local control with prolongation in radiotherapy.

J F Fowler1, M J Lindstrom.   

Abstract

Twelve published clinical results of radical radiotherapy of head and neck cancer have been reviewed, seven of them with fresh multivariate analyses, to determine the magnitude of time factors relating local control to overall time. In all but two of the data sets a significant loss of local control was observed with prolongation. The median rate of loss was 14% in only 1 week, the range 3 to 25%. This corresponds to a median loss of 26% in 2 weeks (5-42%). These results are comparable with other, less detailed information. Whether these significant losses are due to proliferation of tumor cells or to other causes such as physician selection, it is clear that modest prolongation is associated with a lower chance of local control.

Entities:  

Mesh:

Year:  1992        PMID: 1534082     DOI: 10.1016/0360-3016(92)90768-d

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  56 in total

1.  Compliance to the prescribed overall treatment time (OTT) of curative radiotherapy in normal clinical practice and impact on treatment duration of counteracting short interruptions by treating patients on Saturdays.

Authors:  M Maciá I Garau; J Solé Monné; M J Cambra Serés; C Monfà Binefa; M Peraire Llopis
Journal:  Clin Transl Oncol       Date:  2009-05       Impact factor: 3.405

2.  Evaluation of the response of concurrent high dose rate intracavitary brachytherapy with external beam radiotherapy in management of early stage carcinoma cervix.

Authors:  Arvind Kumar Patidar; H S Kumar; Rahul V Walke; Pushpendra H Hirapara; Shankar Lal Jakhar; M R Bardia
Journal:  J Obstet Gynaecol India       Date:  2012-08-17

3.  Cyclopamine-loaded core-cross-linked polymeric micelles enhance radiation response in pancreatic cancer and pancreatic stellate cells.

Authors:  Jun Zhao; Chunhui Wu; James Abbruzzese; Rosa F Hwang; Chun Li
Journal:  Mol Pharm       Date:  2015-05-12       Impact factor: 4.939

Review 4.  Radiobiological considerations in combining doses from external beam radiotherapy and brachytherapy for cervical cancer.

Authors:  Ana M Tornero-López; Damián Guirado
Journal:  Rep Pract Oncol Radiother       Date:  2018-07-02

Review 5.  The effectiveness of mouthwashes in alleviating radiation-induced oral mucositis in head and neck cancer patients: a systematic review.

Authors:  Masaru Konishi; Rinus Gerardus Verdonschot; Kiichi Shimabukuro; Takashi Nakamoto; Minoru Fujita; Naoya Kakimoto
Journal:  Oral Radiol       Date:  2018-12-10       Impact factor: 1.852

6.  Hypofractionated accelerated radiotherapy in T1-3 N0 cancer of the larynx: A prospective cohort study with historical controls.

Authors:  Zbigniew Szutkowski; Andrzej Kawecki; Andrzej Jarząbski; Zofia Laskus; Romuald Krajewski; Wojciech Michalski; Paweł Kukołowicz
Journal:  Rep Pract Oncol Radiother       Date:  2016-09-20

7.  Radiotherapy for elderly patients and cetuximab, a monocentric study.

Authors:  Alexander T Falk; Christophe Hébert; Antoine Tran; Marie-Eve Chand; Axel Leysalle; Juliette Thariat; Olivier Dassonville; Gilles Poissonnet; Alexandre Bozec; Esma Saada; Fréderic Peyrade; Karen Benezery
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-10-11       Impact factor: 2.503

8.  Image-guided Radiotherapy Of Esophageal Cancer By Helical Tomotherapy: Acute Toxicity And Preliminary Clinical Outcome.

Authors:  Yi-Jen Chen; Kemp H Kernstine; Stephen Shibata; Dean Lim; David D Smith; Martin Tang; An Liu; Richard D Pezner; Jeffrey Y C Wong
Journal:  J Thorac Dis       Date:  2009-12       Impact factor: 2.895

9.  Radioprotectors and Radiomitigators for Improving Radiation Therapy: The Small Business Innovation Research (SBIR) Gateway for Accelerating Clinical Translation.

Authors:  Pataje G S Prasanna; Deepa Narayanan; Kory Hallett; Eric J Bernhard; Mansoor M Ahmed; Gregory Evans; Bhadrasain Vikram; Michael Weingarten; C Norman Coleman
Journal:  Radiat Res       Date:  2015-08-18       Impact factor: 2.841

10.  Recombinant human epidermal growth factor treatment of radiation-induced severe oral mucositis in patients with head and neck malignancies.

Authors:  J P Hong; S-W Lee; S Y Song; S D Ahn; S S Shin; E K Choi; J H Kim
Journal:  Eur J Cancer Care (Engl)       Date:  2009-04-23       Impact factor: 2.520

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.